Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Herlyn

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1982
IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cellsD Herlyn, H Koprowski
Annals of Medicine|April 29, 1999
Advances in cancer vaccine developmentD Herlyn, B Birebent
Nihon Ika Daigaku Zasshi|October 1, 1991
[Enhancement of epidermal growth factor receptor (EGF-R) expression on glioma cells by cytokines]K Adachi, D Herlyn
Journal of Immunological Methods|February 25, 1983
Monoclonal antibodies derived from immunosuppressed mice grafted with human melanomaD Herlyn, B Atkinson, H Koprowski
Neurologia Medico-Chirurgica|September 1, 1993
Experimental radioimmunotherapy of a xenografted human glioma using 131I-labeled monoclonal antibody to epidermal growth factor receptorH Takahashi, S Nakazawa, D Herlyn
Clinical and Experimental Immunology|July 1, 1995
Tetanus toxoid-specific T cell responses in severe combined immunodeficiency (SCID) mice reconstituted with human peripheral blood lymphocytesR Somasundaram, L Jacob, D Herlyn
International Reviews of Immunology|January 1, 1989
Modulation of cancer patients' immune responses by anti-idiotypic antibodiesD Herlyn, M Wettendorff, H Koprowski
Journal of Immunological Methods|September 24, 1987
Purification of monoclonal antibodies from ascites using ABx liquid chromatography columnA H Ross, D Herlyn, H Koprowski
Science (New York, N.Y.)|April 4, 1986
Anti-idiotypic antibodies bear the internal image of a human tumor antigenD Herlyn, A H Ross, H Koprowski
Journal of Immunological Methods|December 17, 1985
Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibodyD Herlyn, M Lubeck, H Sears, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1982
IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cellsD Herlyn, H Koprowski
Annals of Medicine|April 29, 1999
Advances in cancer vaccine developmentD Herlyn, B Birebent
Nihon Ika Daigaku Zasshi|October 1, 1991
[Enhancement of epidermal growth factor receptor (EGF-R) expression on glioma cells by cytokines]K Adachi, D Herlyn
Journal of Immunological Methods|February 25, 1983
Monoclonal antibodies derived from immunosuppressed mice grafted with human melanomaD Herlyn, B Atkinson, H Koprowski
Neurologia Medico-Chirurgica|September 1, 1993
Experimental radioimmunotherapy of a xenografted human glioma using 131I-labeled monoclonal antibody to epidermal growth factor receptorH Takahashi, S Nakazawa, D Herlyn
Clinical and Experimental Immunology|July 1, 1995
Tetanus toxoid-specific T cell responses in severe combined immunodeficiency (SCID) mice reconstituted with human peripheral blood lymphocytesR Somasundaram, L Jacob, D Herlyn
International Reviews of Immunology|January 1, 1989
Modulation of cancer patients' immune responses by anti-idiotypic antibodiesD Herlyn, M Wettendorff, H Koprowski
Journal of Immunological Methods|September 24, 1987
Purification of monoclonal antibodies from ascites using ABx liquid chromatography columnA H Ross, D Herlyn, H Koprowski
Science (New York, N.Y.)|April 4, 1986
Anti-idiotypic antibodies bear the internal image of a human tumor antigenD Herlyn, A H Ross, H Koprowski
Journal of Immunological Methods|December 17, 1985
Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibodyD Herlyn, M Lubeck, H Sears, et al.
Pageof 11